SARS-CoV-2 infection predisposes patients to coinfection with
COVID
MRSA
SARS-CoV-2
agr
coinfection
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
22 Jul 2024
22 Jul 2024
Historique:
medline:
22
7
2024
pubmed:
22
7
2024
entrez:
22
7
2024
Statut:
aheadofprint
Résumé
Severe COVID-19 has been associated with coinfections with bacterial and fungal pathogens. Notably, patients with COVID-19 who develop The COVID-19 pandemic has had an enormous impact on healthcare across the globe. Patients who were severely infected with SARS-CoV-2, the virus causing COVID-19, sometimes became infected with other pathogens, which is termed coinfection. If the coinfecting pathogen is the bacterium
Identifiants
pubmed: 39037272
doi: 10.1128/mbio.01667-24
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM